121 related articles for article (PubMed ID: 38197423)
1. Humanization with CD34-positive hematopoietic stem cells in NOG-EXL mice results in improved long-term survival and less severe myeloid cell hyperactivation phenotype relative to NSG-SGM3 mice.
Willis E; Verrelle J; Banerjee E; Assenmacher CA; Tarrant JC; Skuli N; Jacobson ML; O'Rouke DM; Binder ZA; Radaelli E
Vet Pathol; 2024 Jan; ():3009858231222216. PubMed ID: 38197423
[TBL] [Abstract][Full Text] [Related]
2. A Comparison of Lymphoid and Myeloid Cells Derived from Human Hematopoietic Stem Cells Xenografted into NOD-Derived Mouse Strains.
Gutierrez-Barbosa H; Medina-Moreno S; Perdomo-Celis F; Davis H; Coronel-Ruiz C; Zapata JC; Chua JV
Microorganisms; 2023 Jun; 11(6):. PubMed ID: 37375051
[TBL] [Abstract][Full Text] [Related]
3. The Tumor Milieu Promotes Functional Human Tumor-Resident Plasmacytoid Dendritic Cells in Humanized Mouse Models.
Maser IP; Hoves S; Bayer C; Heidkamp G; Nimmerjahn F; Eckmann J; Ries CH
Front Immunol; 2020; 11():2082. PubMed ID: 33013879
[TBL] [Abstract][Full Text] [Related]
4. Development of Mast Cell and Eosinophil Hyperplasia and HLH/MAS-Like Disease in NSG-SGM3 Mice Receiving Human CD34+ Hematopoietic Stem Cells or Patient-Derived Leukemia Xenografts.
Janke LJ; Imai DM; Tillman H; Doty R; Hoenerhoff MJ; Xu JJ; Freeman ZT; Allen P; Fowlkes NW; Iacobucci I; Dickerson K; Mullighan CG; Vogel P; Rehg JE
Vet Pathol; 2021 Jan; 58(1):181-204. PubMed ID: 33208054
[TBL] [Abstract][Full Text] [Related]
5. Establishment of Humanized Mice from Peripheral Blood Mononuclear Cells or Cord Blood CD34+ Hematopoietic Stem Cells for Immune-Oncology Studies Evaluating New Therapeutic Agents.
Verma B; Wesa A
Curr Protoc Pharmacol; 2020 Jun; 89(1):e77. PubMed ID: 32453514
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Human Engraftment and Hemophagocytic Lymphohistiocytosis in NSG-SGM3 Neonate Mice Engrafted with Purified CD34
O'Brien LJ; Walpole CM; Leal-Rojas IM; Shatunova S; Moore A; Winkler IG; Guillerey C; Radford KJ
Exp Hematol; 2024 Feb; 130():104134. PubMed ID: 38052261
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous early-onset neurodegeneration in the brainstem and spinal cord of NSG, NOG, and NXG mice.
Finesso G; Willis E; Tarrant JC; Lanza M; Sprengers J; Verrelle J; Banerjee E; Hermans E; Assenmacher CA; Radaelli E
Vet Pathol; 2023 May; 60(3):374-383. PubMed ID: 36727841
[TBL] [Abstract][Full Text] [Related]
8. Improved B cell development in humanized NOD
Jangalwe S; Shultz LD; Mathew A; Brehm MA
Immun Inflamm Dis; 2016 Dec; 4(4):427-440. PubMed ID: 27980777
[TBL] [Abstract][Full Text] [Related]
9. Next-generation humanized NSG-SGM3 mice are highly susceptible to
Hung S; Kasperkowitz A; Kurz F; Dreher L; Diessner J; Ibrahim ES; Schwarz S; Ohlsen K; Hertlein T
Front Immunol; 2023; 14():1127709. PubMed ID: 36969151
[TBL] [Abstract][Full Text] [Related]
10. HIV Replication in Humanized IL-3/GM-CSF-Transgenic NOG Mice.
Perdomo-Celis F; Medina-Moreno S; Davis H; Bryant J; Zapata JC
Pathogens; 2019 Mar; 8(1):. PubMed ID: 30871027
[TBL] [Abstract][Full Text] [Related]
11. Humanized mouse model of mast cell-mediated passive cutaneous anaphylaxis and passive systemic anaphylaxis.
Bryce PJ; Falahati R; Kenney LL; Leung J; Bebbington C; Tomasevic N; Krier RA; Hsu CL; Shultz LD; Greiner DL; Brehm MA
J Allergy Clin Immunol; 2016 Sep; 138(3):769-779. PubMed ID: 27139822
[TBL] [Abstract][Full Text] [Related]
12. Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rγ(null) humanized mice.
Billerbeck E; Barry WT; Mu K; Dorner M; Rice CM; Ploss A
Blood; 2011 Mar; 117(11):3076-86. PubMed ID: 21252091
[TBL] [Abstract][Full Text] [Related]
13. Kidney Immune Cell Characterization of Humanized Mouse Models.
Noel S; Kurzhagen JT; Lee SA; Sadasivam M; Hamad ARA; Pierorazio PM; Rabb H
Kidney360; 2024 Jan; 5(1):96-109. PubMed ID: 38037230
[TBL] [Abstract][Full Text] [Related]
14. Pathology of macrophage activation syndrome in humanized NSGS mice.
Tarrant JC; Binder ZA; Bugatti M; Vermi W; van den Oord J; Ranieri B; Assenmacher CA; Hoepp N; O'Rourke DM; Shan X; Danet-Desnoyers G; Radaelli E
Res Vet Sci; 2021 Jan; 134():137-146. PubMed ID: 33383491
[TBL] [Abstract][Full Text] [Related]
15. Myeloid Engraftment in Humanized Mice: Impact of Granulocyte-Colony Stimulating Factor Treatment and Transgenic Mouse Strain.
Coughlan AM; Harmon C; Whelan S; O'Brien EC; O'Reilly VP; Crotty P; Kelly P; Ryan M; Hickey FB; O'Farrelly C; Little MA
Stem Cells Dev; 2016 Apr; 25(7):530-41. PubMed ID: 26879149
[TBL] [Abstract][Full Text] [Related]
16. A novel humanized mouse model for HIV and tuberculosis co-infection studies.
Bohórquez JA; Adduri S; Ansari D; John S; Florence J; Adejare O; Singh G; Konduru NV; Jagannath C; Yi G
Front Immunol; 2024; 15():1395018. PubMed ID: 38799434
[TBL] [Abstract][Full Text] [Related]
17. Posttransplant Hemophagocytic Lymphohistiocytosis Driven by Myeloid Cytokines and Vicious Cycles of T-Cell and Macrophage Activation in Humanized Mice.
Yoshihara S; Li Y; Xia J; Danzl N; Sykes M; Yang YG
Front Immunol; 2019; 10():186. PubMed ID: 30814997
[TBL] [Abstract][Full Text] [Related]
18. High activation and skewed T cell differentiation are associated with low IL-17A levels in a hu-PBL-NSG-SGM3 mouse model of HIV infection.
Perdomo-Celis F; Medina-Moreno S; Davis H; Bryant J; Taborda NA; Rugeles MT; Kottilil S; Zapata JC
Clin Exp Immunol; 2020 May; 200(2):185-198. PubMed ID: 31951011
[TBL] [Abstract][Full Text] [Related]
19. Generation of Human Immunosuppressive Myeloid Cell Populations in Human Interleukin-6 Transgenic NOG Mice.
Hanazawa A; Ito R; Katano I; Kawai K; Goto M; Suemizu H; Kawakami Y; Ito M; Takahashi T
Front Immunol; 2018; 9():152. PubMed ID: 29456539
[TBL] [Abstract][Full Text] [Related]
20. BLT-Immune Humanized Mice as a Model for Nivolumab-Induced Immune-Mediated Adverse Events: Comparison of the NOG and NOG-EXL Strains.
Weaver JL; Zadrozny LM; Gabrielson K; Semple KM; Shea KI; Howard KE
Toxicol Sci; 2019 May; 169(1):194-208. PubMed ID: 30850839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
